The epidemiology of chronic fatigue syndrome/myalgic encephalitis in children

Insights

Paediatricians often see children with chronic fatigue syndrome or myalgic encephalitis (CFS/ME), but its prevalence, risk factors, and recovery predictors remain unclear. Recent findings indicate CFS/ME is more common in socially deprived populations than previously assumed.

Area of Science:

  • Pediatrics
  • Chronic Illness Research
  • Epidemiology

Background:

  • Chronic fatigue syndrome or myalgic encephalitis (CFS/ME) is frequently encountered by paediatricians.
  • There is limited understanding regarding the epidemiology of CFS/ME in children, including prevalence, affected demographics, and risk factors.

Purpose of the Study:

  • To review current knowledge on the prevalence, affected populations, risk factors, and recovery predictors of CFS/ME in children.
  • To highlight recent research suggesting a higher incidence of CFS/ME in socially deprived groups.

Main Methods:

  • Literature review of existing research on paediatric CFS/ME.
  • Synthesis of findings on epidemiological data and clinical characteristics.

Main Results:

  • Paediatricians encounter CFS/ME regularly, yet comprehensive data on its occurrence and outcomes in children is scarce.
  • Emerging evidence suggests CFS/ME may be more prevalent in socially deprived populations, challenging previous assumptions.

Conclusions:

  • Further research is crucial to elucidate the epidemiology and predictors of recovery for CFS/ME in paediatric populations.
  • Understanding the socio-economic factors associated with CFS/ME is essential for effective management and intervention.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
29
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
32
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
497
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
219
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
75
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
32